Robert W. Baldridge
Nessuna posizione attualmente
Profilo
Robert W.
Baldridge has been a Director of GTC Biotherapeutics, Inc. since 1994.
He provided consulting services to GTC Biotherapeutics from October 1994 to October 2000.
He has been an Independent Business Consultant since June 1988.
Mr. Baldridge was Chief Executive Officer and Chairman of TSI Corp.
from 1993 to 1994.
Precedenti posizioni note di Robert W. Baldridge
| Società | Posizione | Fine |
|---|---|---|
| REVO BIOLOGICS INC | Direttore/Membro del Consiglio | 01/10/2009 |
| TSI Corp | Presidente | 01/01/1994 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
| TSI Corp | Commercial Services |
- Borsa valori
- Insiders
- Robert W. Baldridge